103 related articles for article (PubMed ID: 22834637)
1. Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours.
Poltronieri P; D'Urso PI; Mezzolla V; D'Urso OF
Chem Biol Drug Des; 2013 Jan; 81(1):79-84. PubMed ID: 22834637
[TBL] [Abstract][Full Text] [Related]
2. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors.
D'Urso PI; D'Urso OF; Storelli C; Mallardo M; Gianfreda CD; Montinaro A; Cimmino A; Pietro C; Marsigliante S
Int J Oncol; 2012 Jul; 41(1):228-34. PubMed ID: 22470130
[TBL] [Abstract][Full Text] [Related]
3. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Yan W; Zhang W; Sun L; Liu Y; You G; Wang Y; Kang C; You Y; Jiang T
Brain Res; 2011 Sep; 1411():108-15. PubMed ID: 21831363
[TBL] [Abstract][Full Text] [Related]
4. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
Liu Y; Yan W; Zhang W; Chen L; You G; Bao Z; Wang Y; Wang H; Kang C; Jiang T
Oncol Rep; 2012 Sep; 28(3):1013-21. PubMed ID: 22766851
[TBL] [Abstract][Full Text] [Related]
5. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
[TBL] [Abstract][Full Text] [Related]
6. Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept.
Halle B; Marcusson EG; Aaberg-Jessen C; Jensen SS; Meyer M; Schulz MK; Andersen C; Kristensen BW
J Neurooncol; 2016 Jan; 126(1):47-55. PubMed ID: 26428358
[TBL] [Abstract][Full Text] [Related]
7. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
Kefas B; Godlewski J; Comeau L; Li Y; Abounader R; Hawkinson M; Lee J; Fine H; Chiocca EA; Lawler S; Purow B
Cancer Res; 2008 May; 68(10):3566-72. PubMed ID: 18483236
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Chan JA; Krichevsky AM; Kosik KS
Cancer Res; 2005 Jul; 65(14):6029-33. PubMed ID: 16024602
[TBL] [Abstract][Full Text] [Related]
10. Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis.
Meng W; Jiang L; Lu L; Hu H; Yu H; Ding D; Xiao K; Zheng W; Guo H; Ma W
Cell Biol Int; 2012 Jul; 36(7):653-9. PubMed ID: 22276743
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
Li Y; Li W; Yang Y; Lu Y; He C; Hu G; Liu H; Chen J; He J; Yu H
Brain Res; 2009 Aug; 1286():13-8. PubMed ID: 19559015
[TBL] [Abstract][Full Text] [Related]
12. Extensive modulation of a set of microRNAs in primary glioblastoma.
Ciafrè SA; Galardi S; Mangiola A; Ferracin M; Liu CG; Sabatino G; Negrini M; Maira G; Croce CM; Farace MG
Biochem Biophys Res Commun; 2005 Sep; 334(4):1351-8. PubMed ID: 16039986
[TBL] [Abstract][Full Text] [Related]
13. Efficient in vivo microRNA targeting of liver metastasis.
Huynh C; Segura MF; Gaziel-Sovran A; Menendez S; Darvishian F; Chiriboga L; Levin B; Meruelo D; Osman I; Zavadil J; Marcusson EG; Hernando E
Oncogene; 2011 Mar; 30(12):1481-8. PubMed ID: 21102518
[TBL] [Abstract][Full Text] [Related]
14. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.
Fowler A; Thomson D; Giles K; Maleki S; Mreich E; Wheeler H; Leedman P; Biggs M; Cook R; Little N; Robinson B; McDonald K
Eur J Cancer; 2011 Apr; 47(6):953-63. PubMed ID: 21196113
[TBL] [Abstract][Full Text] [Related]
15. TNF-α is a novel target of miR-19a.
Liu M; Wang Z; Yang S; Zhang W; He S; Hu C; Zhu H; Quan L; Bai J; Xu N
Int J Oncol; 2011 Apr; 38(4):1013-22. PubMed ID: 21271217
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
17. miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells.
Hao J; Zhang C; Zhang A; Wang K; Jia Z; Wang G; Han L; Kang C; Pu P
Oncol Rep; 2012 May; 27(5):1504-10. PubMed ID: 22294051
[TBL] [Abstract][Full Text] [Related]
18. Targeting malignant glioma survival signalling to improve clinical outcomes.
Wong ML; Kaye AH; Hovens CM
J Clin Neurosci; 2007 Apr; 14(4):301-8. PubMed ID: 17276069
[TBL] [Abstract][Full Text] [Related]
19. [Up-regulation of p27(kip1) by miR-221/222 antisense oligonucleotides enhances the radiosensitivity of U251 glioblastoma].
Zhang C; Wang G; Kang C; Du Y; Pu P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Dec; 26(6):634-8. PubMed ID: 19953484
[TBL] [Abstract][Full Text] [Related]
20. [New glioma therapy using specific microRNAs].
Halle B; Andersen C; Schulz MK; Kristensen BW
Ugeskr Laeger; 2012 Mar; 174(10):630-3. PubMed ID: 22395010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
